long COVID

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

The Scientist asks Brigham and Women’s Hospital infectious disease specialist Lindsey Baden about testing for prior infections.

Stressed cells can form hollow actin bridges to neighbors to get help, but the virus may hijack these tiny tunnels for its own purposes, a study suggests.

People who were vaccinated at least six months prior to infection had the lowest risk of lasting symptoms in a UK study.

A new presidential memorandum requires the Department of Health and Human Services to coordinate a government-wide push to generate a research action plan for the condition.

The first part of 2022 is giving us a glimpse of humanity’s future relationship with COVID-19.

And does it even matter?

A study that examined the brains of people before and after SARS-CoV-2 infection found a decrease in brain volume and damage to olfactory areas compared with controls.

Data from mouse models for mild coronavirus infections and human tissue samples offer further evidence that it doesn’t take a severe infection—or even infection of brain cells at all—to cause long-term neurological symptoms.

Two recent papers provide insight into possible risk factors for developing the chronic condition, including autoantibodies and diabetes.

Experts have a decent grasp on how COVID-19 impacts cardiovascular health in the near term. The implications of long COVID, however, remain mysterious.

The study aims to recruit 40,000 adults and children to get a better sense of the condition that can last weeks or months after infection.

Symptoms documented in cases of long COVID are wide ranging and variable.

A year and a half into the pandemic, the long-term effects of SARS-CoV-2 infection are garnering more research attention as millions of long COVID patients emerge.

An ability to build up higher concentrations of viral particles in people’s airways and mutations that might boost its ability to infect human cells could be what gives the Delta variant its evolutionary edge.

Clinics are popping up around the US to study the sometimes long-lasting effects of SARS-CoV-2 infection in children and teens.

From new treatments to an investigation into the virus’s origins, here are some of the developments we can expect this year.

A handful of viruses have been associated with long-term, debilitating symptoms in a subset of those who become infected. Early signs hint that SARS-CoV-2 may do the same.